Renal sympathetic denervation ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
67Polycystic kidney disease1

67. Polycystic kidney disease


Clinical trials : 216 Drugs : 219 - (DrugBank : 50) / Drug target genes : 39 - Drug target pathways : 151
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01932450
(ClinicalTrials.gov)
August 201318/8/2013Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression ControlA Randomized, Open-label Study Investigating the Effect of Bilateral Renal Artery Sympathetic Denervation by Catheter-based Radiofrequency Ablation on Blood Pressure and Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseAutosomal Dominant Polycystic Kidney Disease;HypertensionProcedure: renal sympathetic denervation;Drug: antihypertensive drugsMei changlinNULLRecruiting20 Years60 YearsBoth100Phase 2China